TRP-8802 demonstrated significant and prolonged improvement in primary endpoints for all five patients Across all patients treated with TRP-8802, daily binge eating episodes were reduced by an average ...
KELOWNA, BC / ACCESSWIRE / December 11, 2023 / Tryp Therapeutics Inc. ("Tryp" or the "Company") (CSE:TRYP), a clinical-stage biotechnology company focused on developing intravenous-infused psilocin ...
Deep-rooted psychological factors are often at the core of eating disorders, and psilocybin is increasingly showing promise. As treatment advances, Tryp Therapeutics developed psilocybin-based ...
Psilocybin, the active ingredient found in what's often referred to as "magic mushrooms," has been a popular topic of late. The substance has experienced a surge in popularity over the past few years, ...
KELOWNA, BC / ACCESSWIRE / August 3, 2023 / Tryp Therapeutics Inc. (CSE:TRYP)(OTCQB:TRYPF) ("Tryp" or the "Company"), a clinical-stage biotechnology company dedicated to developing intravenous-infused ...
Tryptamine Therapeutics (AU:TYP) has released an update. Tryptamine Therapeutics Limited, a clinical-stage biotech company, has shifted its principal business address to a new location in Camberwell, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback